MEDIZINISCHE UNIVERSITÄT GRAZ Patent applications |
Patent application number | Title | Published |
20150032201 | BIO-ABSORBABLE COMPOSITE MATERIALS CONTAINING MAGNESIUM AND MAGNESIUM ALLOYS AS WELL AS IMPLANTS MADE OF SAID COMPOSITES - The invention relates to a composite material that comprises at least one magnesium component, whereby the magnesium component consists of pure magnesium or a magnesium-calcium alloy or a magnesium-calcium-X alloy, whereby X is another biodegradable element. The composite material also contains at least one organic anti-infective agent having a solubility in water at room temperature of less than 10 grams per liter. | 01-29-2015 |
20140024702 | CANCER GENE THERAPY USING NUCLEIC ACIDS ENCODING US28 AND G-PROTEIN - The invention relates to the gene therapeutic treatment of cancer using co-expressed nucleic acids encoding US28 and a G-protein. e.g. GNA-13, or functional fragments thereof, or using nucleic acids encoding fusion polypeptides of US28 and a G-protein or functional fragments thereof. The pharmaceutical compositions according to the invention are used in the treatment of cancer patients to induce apoptosis in tumor cells. | 01-23-2014 |
20130060266 | NEURAL PROSTHESIS AND METHOD FOR PRODUCING A NEURAL PROSTHESIS - The invention relates to a neural prosthesis, a neural prosthesis for use in the treatment of severed nerves and to a method for producing a neural prosthesis. Said neural prosthesis comprises a coupling element receptacle and at least one coupling element having a first and a second coupling section, wherein the coupling element is fixed by the coupling element receptacle, and wherein the first coupling section can be arranged on a first nerve region and the second coupling section on a second nerve region so that both nerve regions can be coupled by means of the neural prosthesis. | 03-07-2013 |
20130052671 | IL-6 DETECTION BASED EARLY DIAGNOSIS AND PREDICTION OF SYSTEMATIC INFLAMMATORY RESPONSE SYNDROME AND SEPSIS IN ASYMPTOMATIC PATIENTS - Methods, systems and kits for the early diagnosis or prediction of systemic inflammatory response syndrome (SIRS) including sepsis in asymptomatic patients, such as patients undergoing a surgical intervention, are provided. Some embodiments include a method and system for the detection or diagnosis of SIRS, or detection or diagnosis of a risk to suffer from or develop SIRS, in an asymptomatic patient comprising the steps of determining the level of IL-6 (or a variant thereof) in a sample from the patient; comparing the level of IL-6 (or a variant thereof) to a reference level; detecting or diagnosing SIRS or diagnosing a risk to suffer from or develop SIRS, wherein the sample is isolated at least 2 times at short intervals and the determining and comparing steps are both repeated for each sample. Also provided are methods, systems and kits for therapy monitoring and mortality prediction. | 02-28-2013 |
20120258483 | METHOD FOR DETECTING A WOUND INFECTION - The present invention relates to a method for detecting a wound infection comprising the steps of: contacting a sample obtained from a wound with at least two substrates for at least two enzymes selected from the group consisting of lysozyme, elastase, cathepsin G and myeloperoxidase, and detecting a wound infection when a conversion of the at least two substrates with said at least two enzymes are determined. | 10-11-2012 |
20100168551 | Determining a Thickness of a Layer of Fat of an Organism - An apparatus for determining a thickness of a layer of fat of an organism, the apparatus comprising a plurality of electromagnetic radiation sources adapted for illuminating the layer of fat with a plurality of pulses of electromagnetic radiation, at least one electromagnetic radiation detector adapted for detecting detection signals indicative of the pulses of electromagnetic radiation after transmission through the layer of fat, and a determining unit adapted for determining a plurality of values of the thickness of the layer of fat based on an analysis of a plurality of ratios between the detection signals, wherein only those values are used for calculating an average thickness of the layer of fat which values result in deviations from the average thickness of less than a predetermined threshold value. | 07-01-2010 |
20090163459 | Use of 24-nor-UDCA - The present invention relates to the use of nor-ursodeoxycholic acid for the manufacture of a drug for the treatment and/or the prevention of liver diseases, preferably chronic liver diseases. | 06-25-2009 |